CONTENTS:
- Alcohol and other drug neuroscience: Expanding the scope of JSAD. Read J.P., p. 5.
- The value of neuroscience-based approaches for the study of alcohol and other drugs. Torregrossa M.M., p. 6-7.
- Effects of the Federal Government's move to reschedule cannabis: A commentary. Collins R.L., Thanos P.K., Ashare R., Herzberg D., Silverman R., p. 8-12.
- Disaggregating trends in alcohol involvement among Hispanic, Black, and White female and male U.S. adolescents: 2002 to 2019. Perrotte J.K., Castro Y., Martinez P., Field C.A., Pinedo M., Schepis T.S., p. 13-24.
- Prevalence of cannabis use disorder: A meta-analysis of population surveys. Boness C.L., Pfund R.A., Acuff S., Montano-Pilch M., Sher K.J., p. 25-38.
- Solitary drinkers in Great Britain: How do their sociodemographic characteristics, consumption patterns, and drinking occasions differ from those who drink with others? Wilson L.B., Bain M., Hernandez-Alava M., Holmes J., Pryce R., Sasso A., et al., p. 39-47.
- Trends of buprenorphine prescribing for opioid dependence before and during the early and later part of the COVID-19 pandemic: A study from a large, publicly funded opioid agonist treatment service in India. Ghosh A., Basu D., Kaur S., Naik S.S., Subodh B.N., Mattoo S.K., p. 48-57.
- Profile of chronic pain patients with opioid withdrawal syndrome according to psychological factors: A latent class analysis. Rodriguez-Espinosa S., Coloma-Carmona A., Pérez-Carbonell A., Roman-Quiles J.F., Carballo J.L., p. 58-67.
- A national survey study of cannabis use during menopause: Identifying variables associated with recreational, medical, and hybrid use. Dahlgren M.K., Kosereisoglu D., Sagar K.A., Smith R.T., El-Abboud C., Lambros A.M., et al., p. 68-74.
- Mandatory warning signs for cannabis: Perspectives and preferences of pregnant and recently pregnant people who use cannabis. Gould H., Zaugg C., Biggs M.A., Woodruff K., Long W., Mailman K., et al., p. 75-84.
- The longitudinal association of cumulative depression with cannabis use disorder among young adults. Rhew I.C., Oesterle S., Kuklinski M.R., Guttmannova K., Cadigan J.M., p. 85-94.
- Protective role of ellagic acid against ethanol-induced neurodevelopmental disorders in newborn male rats: Insights into maintenance of mitochondrial function and inhibition of oxidative stress. Jamali Z., Salimi A., Khezri S., Norozi P., Garmabi B., Khaksari M., p. 95-105.
- Prevalence and characteristics of alcohol use in substance-involved deaths in St. Louis, Missouri, from 2011 to 2022. Nance M., Richardson J., Stetsiv K., Banks D., Paschke M., Winograd R., et al., p. 106-114.
- Daily-level associations between situational familiarity with location and people and use of alcohol-related protective behavioral strategies among adolescents and young adults. Cross A., Zhou Z., Fairlie A.M., Litt D.M., Graupensperger S., Lee C.M., et al., p. 115-123.
- Examining whether young adults differ in their endorsement and subjective evaluation of alcohol consequences by age, drinking frequency, and current undergraduate status. Walukevich-Dienst K., Hoang A.N., Fairlie A.M., Lewis M.A., Lee C.M., p. 124-135.
- Long-term effects of a multi-component community-level intervention to reduce single-vehicle nighttime crashes: Follow-up findings from a 24-community randomized trial. Saltz R., Paschall M.J., p. 136-139.
- Messages about tobacco and alcohol co-users. Ranney L.M., Kowitt S.D., Jarman K.L., Lane R.M., Goldstein A.O., Cornacchione Ross J., et al., p. 140-148.
- Do we need additional indicators for the Sustainable Development Goal Target 3.5 on strengthening the prevention and treatment of substance abuse? An analysis of recent submissions to the UN Inter-Agency and Expert Group. Rehm J., Shield K., p. 149-152.